INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
AstraZeneca jab Conditional Marketing Authorisation (CMA) got more holes than Swiss cheese

AstraZeneca jab Conditional Marketing Authorisation (CMA) got more holes than Swiss cheese

Why aren't UK lawyers jumping on this? Jabs have been injuring people!!!

Hedley Rees's avatar
Hedley Rees
May 19, 2023
∙ Paid
15

Share this post

INSIDE PHARMA
INSIDE PHARMA
AstraZeneca jab Conditional Marketing Authorisation (CMA) got more holes than Swiss cheese
26
1
Share

MHRA ‘invented’ a dangerous system of approval

The Conditional Marketing Authorisation (CMA) used to authorise the SARS-CoV-2 jabs for sale in the UK was a global pharmaceutical industry first. MHRA led the field when it approved the Pfizer/BioNTech jabs. Ever since, MHRA has beaten every regulatory agency to the punch, by approving new injections under its CMA process.

So, how confident can UK subjects be, when lining up to take the AZ jab, that this fantastic new ‘accelerated’ process was NOT going to do them harm?

What follows is a description of a process that was so full of holes, gaps and omissions as to make the jabs guaranteed to injure ‘some’ unsuspecting receivers.

This is an extract from the UK.GOV/MHRA website link above:

Guidance for Great Britain Conditional Marketing Authorisation Applications

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share